Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
ResMed Inc.’s Chief Commercial Officer, Kaushik Ghoshal, executed a transaction involving the acquisition and sale of 4,260 shares of ResMed common stock under a pre-established Rule 10b5-1 plan. The shares were acquired at $101.64 per share and sold at $238.48 per share, reflecting a strategic financial move. This transaction highlights Ghoshal’s active role in managing his stake in the company amidst the evolving market dynamics.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
